Listed on GrantGunner. Last checked 16 Nov 2026.
About this grant
A specialized accelerator program designed for high-potential companies operating at the intersection of health technology, digital biotech, and pharmaceutical research and development. The three-month hybrid program helps early-stage founders refine value propositions and build partnerships in the global pharmaceutical industry, offering mentorship and access to the Basel life sciences network.